174 related articles for article (PubMed ID: 37542236)
41. Determinants of willingness to pay for self-paid vaccines in China.
Hou Z; Jie Chang ; Yue D; Fang H; Meng Q; Zhang Y
Vaccine; 2014 Jul; 32(35):4471-4477. PubMed ID: 24968160
[TBL] [Abstract][Full Text] [Related]
42. Developing a seasonal influenza vaccine recommendation in Kenya: Process and challenges faced by the National Immunization Technical Advisory Group (NITAG).
Dawa J; Chaves SS; Ba Nguz A; Kalani R; Anyango E; Mutie D; Muthoka P; Tabu C; Maritim M; Amukoye E; Were F;
Vaccine; 2019 Jan; 37(3):464-472. PubMed ID: 30502070
[TBL] [Abstract][Full Text] [Related]
43. Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile.
Graña MG; Cavada G; Vasquez M; Shen J; Maervoet J; Klint J; Gómez JA
Hum Vaccin Immunother; 2021 Dec; 17(12):5603-5613. PubMed ID: 34890520
[TBL] [Abstract][Full Text] [Related]
44. Changes and remaining challenges for the Japanese immunization program: Closing the vaccine gap.
Saitoh A; Okabe N
Vaccine; 2021 May; 39(22):3018-3024. PubMed ID: 33931250
[TBL] [Abstract][Full Text] [Related]
45. How rural and urban parents describe convenience in the context of school-based influenza vaccination: a qualitative study.
Lind C; Russell ML; Collins R; MacDonald J; Frank CJ; Davis AE
BMC Health Serv Res; 2015 Jan; 15():24. PubMed ID: 25608974
[TBL] [Abstract][Full Text] [Related]
46. Parents' attitude, awareness and behaviour towards influenza vaccination in Pakistan.
Bukhsh A; Rehman H; Mallhi TH; Ata H; Rehman IU; Lee LH; Goh BH; Khan TM
Hum Vaccin Immunother; 2018 Apr; 14(4):952-957. PubMed ID: 29333939
[TBL] [Abstract][Full Text] [Related]
47. Estimating national, regional and provincial cost-effectiveness of introducing childhood 13-valent pneumococcal conjugate vaccination in China: a modelling analysis.
Lai X; Garcia C; Wu D; Knoll MD; Zhang H; Xu T; Jing R; Yin Z; Wahl B; Fang H
Lancet Reg Health West Pac; 2023 Mar; 32():100666. PubMed ID: 36785861
[TBL] [Abstract][Full Text] [Related]
48. Strengthening vaccination policies in Latin America: an evidence-based approach.
Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
[TBL] [Abstract][Full Text] [Related]
49. [Introduction and application recommendations of National Immunization Program(NIP) and non-NIP vaccine in China].
Liu ZQ; Bai YH; Zheng DY
Zhonghua Er Ke Za Zhi; 2020 Jun; 58(6):524-526. PubMed ID: 32521970
[TBL] [Abstract][Full Text] [Related]
50. The free vaccination policy of influenza in Beijing, China: The vaccine coverage and its associated factors.
Lv M; Fang R; Wu J; Pang X; Deng Y; Lei T; Xie Z
Vaccine; 2016 Apr; 34(18):2135-40. PubMed ID: 26917011
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of immunization status in patients with cerebral palsy: a multicenter CP-VACC study.
Bozkaya-Yilmaz S; Karadag-Oncel E; Olgac-Dundar N; Gencpinar P; Sarioglu B; Arican P; Ersen A; Yilmaz-Ciftdoğan D; Yuksel MF; Bektas O; Teber S; Kilic B; Calik M; Karaca M; Canpolat M; Kumandas S; Per H; Gumus H; Ozturk S; Okuyaz C; Komur M; Ipek R; Ozbudak P; Arhan E; Ince H; Gurbuz G; Mert GG; Ozcan N; Turker AO; Gazeteci-Tekin H; Kırık S; Günbey C; Çarman KB; Yarar C; Çavuşoğlu D
Eur J Pediatr; 2022 Jan; 181(1):383-391. PubMed ID: 34355277
[TBL] [Abstract][Full Text] [Related]
52. [Coverage rate and adverse reactions of National Immunization Program vaccines in children with spinal muscular atrophy: a cross-sectional retrospective cohort study].
Qu YJ; Tian YL; Song F; Wang J; Bai JL; Cao YY; Jin YW; Wang H; Cheng MM
Zhonghua Er Ke Za Zhi; 2020 Apr; 58(4):308-313. PubMed ID: 32234138
[No Abstract] [Full Text] [Related]
53. Parents' perception and their decision on their children's vaccination against seasonal influenza in Guangzhou.
He L; Liao QY; Huang YQ; Feng S; Zhuang XM
Chin Med J (Engl); 2015 Feb; 128(3):327-41. PubMed ID: 25635428
[TBL] [Abstract][Full Text] [Related]
54. Awareness, knowledge and attitude toward influenza vaccination in several population groups in China: A cross-sectional study.
Jiang B; Wang Z; Jia M; Yan H; Su Z; Liu S; Yang W; Qiao YL; Feng L
Front Public Health; 2022; 10():950532. PubMed ID: 36330121
[TBL] [Abstract][Full Text] [Related]
55. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
[TBL] [Abstract][Full Text] [Related]
56. Effectiveness of a smartphone app on improving immunization of children in rural Sichuan Province, China: a cluster randomized controlled trial.
Chen L; Du X; Zhang L; van Velthoven MH; Wu Q; Yang R; Cao Y; Wang W; Xie L; Rao X; Zhang Y; Koepsell JC
BMC Public Health; 2016 Aug; 16(1):909. PubMed ID: 27581655
[TBL] [Abstract][Full Text] [Related]
57. A review of rotavirus vaccine use in Asia and the Pacific regions: challenges and future prospects.
Buchy P; Chen J; Zhang XH; Benninghoff B; Lee C; Bibera GL
Expert Rev Vaccines; 2021 Dec; 20(12):1499-1514. PubMed ID: 33275065
[TBL] [Abstract][Full Text] [Related]
58. Psychosocial correlates of intention to receive an influenza vaccination among rural adolescents.
Painter JE; Sales JM; Pazol K; Wingood GM; Windle M; Orenstein WA; DiClemente RJ
Health Educ Res; 2010 Oct; 25(5):853-64. PubMed ID: 20603385
[TBL] [Abstract][Full Text] [Related]
59. [Hesitancy of parents towards vaccines in national immunization program in three regions in China: a cross-sectional study].
Zhao TS; Liu HY; Zheng H; Han BF; Liu B; Liu J; Zhao CY; Li XJ; Yang SB; Du J; Huang NH; Lu QB; Liu YQ; Cui FQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Sep; 42(9):1615-1620. PubMed ID: 34814592
[No Abstract] [Full Text] [Related]
60. Vaccine events raising public concern and associated immunization program policy and practice changes, China, 2005-2021.
Liu X; Yu W; Yin Z; Rodewald L; Song Y; Zhang Z; Ye J; Li L; Cao L; Cao L
Vaccine; 2022 Apr; 40(18):2561-2567. PubMed ID: 35339307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
